COCRYSTAL PHARMA, INC. Net Income (Loss) Available to Common Stockholders, Diluted
COCRYSTAL PHARMA, INC. (COCP) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$1.76 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2014-11-14
- COCRYSTAL PHARMA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2014-09-30 was -$1.76M.
- COCRYSTAL PHARMA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2014-06-30 was -$909.00K.
- COCRYSTAL PHARMA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-09-30 was -$1.00M.
- COCRYSTAL PHARMA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-06-30 was -$1.03M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2014-09-30 | -$1.76M 10-Q · filed 2014-11-14 | -$2.67M derived: sum of 2 quarters · filed 2014-11-14 | -$5.14M 10-Q · filed 2014-11-14 |
| 2014-06-30 | -$909.00K 10-Q · filed 2014-08-14 | -$3.39M 10-Q · filed 2014-08-14 | |
| 2013-09-30 | -$1.00M 10-Q · filed 2014-11-14 | -$2.04M derived: sum of 2 quarters · filed 2014-11-14 | -$3.09M 10-Q · filed 2014-11-14 |
| 2013-06-30 | -$1.03M 10-Q · filed 2014-08-14 | -$2.09M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |